The leading U.S. liquefied natural gas exporter, Cheniere Energy, has declared a quarterly cash dividend of $0.555 per share, reinforcing its commitment to shareholder returns even as analysts adjust near-term price targets.
Analysts at Piper Sandler have slightly lowered their price target for Expand Energy (EXE), the natural gas giant formed from a recent mega-merger, reflecting near-term pressures but maintaining a bullish long-term outlook for the sector.
Chevron is significantly increasing crude exports from Venezuela to the United States, capitalizing on a special U.S. license and growing demand from Gulf Coast refineries, while new competitors enter the recently reopened market.
ExxonMobil has begun commercial operations of a significant carbon capture and storage venture with CF Industries in Louisiana, marking a key step in its strategy to become a leading player in the emerging CCS network along the U.S. Gulf Coast.
A former investment advisor with ties to major Wall Street firms has been sentenced to six years behind bars for orchestrating a million-dollar fraud scheme, using client funds to finance a luxury lifestyle that included high-end cars and country club memberships.
President Trump's nomination of former Fed Governor Kevin Warsh to lead the central bank has ignited market speculation over the future path of interest rates, with analysts divided on whether his leadership would mean more cuts or a return to hawkish restraint.
Regeneron Pharmaceuticals is positioning its experimental obesity drug, olatorepatide, as a potential game-changer by combining significant weight loss with a dramatic reduction in 'bad' cholesterol. The company believes this dual benefit could carve out a unique niche in the competitive $150 billion market, currently led by Novo Nordisk and Eli Lilly.
Franklin Templeton reported robust first-quarter results, with record long-term inflows of $118.6 billion, driven by strong demand across public and private markets. CEO Jenny Johnson highlighted the firm's strategic positioning in AI, blockchain tokenization, and integrated portfolio solutions as investors seek resilience amid ongoing market volatility.
Chevron capped off a year of strategic execution with record global production and industry-leading free cash flow growth, while outlining ambitious expansion plans from the Caspian to the Caribbean.
Amidst a choppy market, value investors are hunting for bargains. We spotlight three companies—Dingdong, Origin Bancorp, and ATRenew—whose current share prices appear significantly disconnected from their estimated intrinsic value, presenting potential opportunities for the discerning investor.
Despite posting a Q4 net loss, Covenant Logistics signals a shift in market dynamics, with executives pointing to rising spot rates, secured contract increases, and a disciplined fleet strategy as precursors to a stronger performance by late 2026.
Amid a cautiously optimistic market backdrop, companies where executives hold significant stakes are drawing investor attention. We examine three such firms where insider buying and strategic moves signal confidence in long-term growth.
Meta Platforms announces a 10% workforce reduction in its Reality Labs division, signaling a strategic shift away from its massive metaverse investments toward artificial intelligence and augmented reality, raising questions about the company's future profitability and stock performance.
While major indices hold steady, a search for growth is turning the spotlight onto smaller companies. We examine three small-cap stocks—from insurance to banking to luxury watches—that are posting strong results and navigating unique challenges in the current market.
As markets swing between optimism and caution, income-focused investors are turning to dividend payers for potential stability. We analyze three stocks offering yields from 3.5% to over 10%, each with a distinct risk and reward profile.
The White House has backed away from plans to set minimum prices for domestic critical minerals projects, telling industry leaders that ventures must stand on their own financially. The policy reversal, driven by funding uncertainties and market concerns, marks a significant shift in strategy for bolstering the U.S. supply chain.
MKS Instruments' recent €1 billion debt offering to refinance its balance sheet arrives as its stock rides a powerful rally, forcing investors to weigh strong operational momentum against a valuation that appears stretched.
Shares of diabetes care innovator Insulet have tumbled nearly 10% year-to-date, sparking a fierce debate among investors. While a key valuation model suggests the stock is deeply undervalued, its sky-high P/E ratio tells a conflicting story. We examine the numbers and what they mean for the future of the Omnipod maker.
Regional airline SkyWest, Inc. has locked in multi-year contract extensions with United Airlines and Delta Air Lines for its Embraer E175 aircraft, providing a stable foundation for growth and improved financial visibility. The agreements solidify the company's fleet strategy and partnership with Embraer amid a competitive landscape.
Amneal Pharmaceuticals' shares have surged over 64% in the past year, prompting investors to question if the rally still has room to run. A closer look at valuation metrics suggests the generic drugmaker may still be trading at a significant discount to its intrinsic value.
